Explore 4F-MPH | PiHKAL · info

Exploring 4F-MPH. To explore a different substance…

Names

4F-MPH
4-Fluoromethylphenidate

IUPAC name

Methyl (4-fluorophenyl)(piperidin-2-yl)acetate

ID 630 · Formula C₁₄H₁₈FNO₂ · Molecular weight 251.297

InChI InChI=1S/C14H18FNO2/c1-18-14(17)13(12-4-2-3-9-16-12)10-5-7-11(15)8-6-10/h5-8,12-13,16H,2-4,9H2,1H3

InChI Key XISBAJBPDVRSPG-UHFFFAOYSA-N This stereoisomer Any stereoisomer

SMILES COC(=O)C(c1ccc(cc1)F)C1CCCCN1

ChemSpider 103880814
PubChem 70876096
Wikipedia 4-Fluoromethylphenidate
Wikipedia, see also List of methylphenidate analogues
PsychonautWiki 4F-MPH
Project Response 4F-MPH (1352-15)
swgdrug.org 4-Fluoromethylphenidate
aipsin.com 4-FMPH (4-Fluoromethylphenidate) (Iss. 18, Jun 2021: X-112)
aipsin.com 4-FMPH (4-Fluoromethylphenidate) (Iss. 12, Dec 2020: X-92)
aipsin.com 4-FMPH (Iss. 4, Oct-Dec 2019: X-45)

Klare, H; Neudörfl, JM; Brandt, SD; Mischler, E; Meier-Giebing, S; Deluweit, K; Westphal, F; Laussmann, T. Analysis of six “neuro-enhancing” phenidate analogs Drug Test. Anal., 1 Mar 2017, 9 (3), 423-435. 1.4 MB. https://doi.org/10.1002/dta.2161 GC,MS,NMR,other

McLaughlin, G; Morris, N; Kavanagh, PV; Power, JD; Dowling, G; Twamley, B; O’Brien, J; Hessman, G; Murphy, B; Walther, D; Partilla, JS; Baumann, MH; Brandt, SD. Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo- and (±)-erythro- diastereomers. Drug Test. Anal., 1 Mar 2017, 9 (3), 347-357. 1.9 MB. https://doi.org/10.1002/dta.2167 GC,LC,MS,NMR,other

Brandt, SD; Kavanagh, PV. Addressing the challenges in forensic drug chemistry Drug Test. Anal., 1 Mar 2017, 9 (3), 342-346. 120 kB. https://doi.org/10.1002/dta.2169

Luethi, D; Kaeser, PJ; Brandt, SD; Krähenbühl, S; Hoener, MC; Liechti, ME. Pharmacological profile of methylphenidate-based designer drugs Neuropharmacology, 15 May 2018, 134 (A), 133-140. 987 kB. https://doi.org/10.1016/j.neuropharm.2017.08.020

EMCDDA. New drugs in Europe, 2015, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2016. 1.0 MB. #76

Adamowicz, P; Zuba, D. Discrimination among designer drug isomers by chromatographic and spectrometric methods In Chromatographic Techniques in the Forensic Analysis of Designer Drugs; Kowalska, T; Sajewicz, M; Sherma, J, Eds., CRC Press, Taylor & Francis Group, 1 Jan 2018; pp 211–232. 1.1 MB. LC,MS,IR,UV

Luethi, D; Liechti, ME. Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics Int. J. Neuropsychoph., 1 Oct 2018, 21 (10), 926–931. 254 kB. https://doi.org/10.1093/ijnp/pyy047 #S1 Piperidines 4-Fluoromethylphe

Carlier, J; Giorgetti, R; Varì, MR; Pirani, F; Ricci, G; Busardò, FP. Use of cognitive enhancers: methylphenidate and analogs Eur. Rev. Med. Pharmacol. Sci., 1 Jan 2019, 23 (1), 3–15. 676 kB. https://doi.org/10.26355/eurrev_201901_16741 #4F-TMP

2C-EF-FLY

9649

7 Dec 2019 · · Isomer Design